Prognostic implications of peripheral artery disease in coronary artery disease
| Autor: | Raffaele Bugiardini, Edina Cenko, Olivia Manfrini, Peter Louis Amaduzzi |
|---|---|
| Přispěvatelé: | Manfrini, Olivia, Amaduzzi, Peter Loui, Cenko, Edina, Bugiardini, Raffaele |
| Rok vydání: | 2017 |
| Předmět: |
medicine.medical_specialty
Arterial disease Population Disease risk stratification Coronary Artery Disease 030204 cardiovascular system & hematology peripheral artery disease Coronary artery disease 03 medical and health sciences Peripheral Arterial Disease 0302 clinical medicine Internal medicine Drug Discovery medicine Myocardial Revascularization Humans In patient 030212 general & internal medicine Acute Coronary Syndrome education Pharmacology education.field_of_study business.industry Incidence (epidemiology) medicine.disease Prognosis Peripheral Blood pressure Cardiology business prognosi management |
| Zdroj: | Current opinion in pharmacology. 39 |
| ISSN: | 1471-4973 |
| Popis: | Prevalence of peripheral arterial disease in patients with coronary artery disease is considerably higher than in the general population. A graded increase in the risk of major cardiovascular events in a variety of clinical settings is associated with the number of arterial beds affected by peripheral arterial disease. This is not surprising, considering that both coronary artery disease and peripheral arterial disease are linked to a higher prevalence of cardiovascular risk factors and a greater incidence of atherosclerotic burden. Aggressive lipid lowering therapy is associated with less coronary and peripheral arterial disease progression and greater regression. On the contrary, blood pressure therapy should be carefully managed, considering the association of both high and low values of pressure with adverse outcomes. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect